Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences, Inc. (RNA) Change in Acquisitions & Divestments (2021 - 2025)

Avidity Biosciences' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $223.6 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 5.54% year-over-year to $223.6 million; the TTM value through Dec 2025 reached $1.1 billion, up 85.24%, while the annual FY2025 figure was $1.1 billion, 85.24% up from the prior year.
  • Change in Acquisitions & Divestments reached $223.6 million in Q4 2025 per RNA's latest filing, down from $269.6 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $330.2 million in Q1 2025 to a low of $3.0 million in Q4 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $136.2 million, with a median of $103.5 million recorded in 2023.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 2657.67% in 2022, then dropped 5.54% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $3.0 million in 2021, then skyrocketed by 2657.67% to $82.7 million in 2022, then grew by 27.78% to $105.7 million in 2023, then surged by 123.96% to $236.7 million in 2024, then dropped by 5.54% to $223.6 million in 2025.
  • Per Business Quant, the three most recent readings for RNA's Change in Acquisitions & Divestments are $223.6 million (Q4 2025), $269.6 million (Q3 2025), and $262.8 million (Q2 2025).